It was reported that tumor cells can release the exosome containing PD‐L1 to inhibit the in vivo antitumor response.[83] And how to stop in situ tumor‐derived vesicle generation when the treatment is over is also a question to be considered. The gene discussed is CD274; the disease is neoplasm.